Monitoring Agency Report for the quarter ended June 30, 2025 is attached.
WELSPLSOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Welspun Specialty Solutions has submitted the Monitoring Agency Report from CARE Ratings for the quarter ended June 30, 2025, covering utilization of proceeds from its Rights Issue of Rs. 349.85 crore held in March 2025. Of the total, Rs. 284 crore was earmarked for repaying/prepaying company borrowings and Rs. 63.56 crore for general corporate purposes, with Rs. 2.29 crore for issue expenses. The entire Rs. 349.85 crore has been fully utilized, with the general corporate portion used for Rs. 32.66 crore in LC payments and Rs. 27 crore for redeeming preference shares. The monitoring agency confirmed no deviations from the stated objects and that all proceeds were deployed as per the offer document.
For shareholders, this is a routine compliance update confirming that the company used the rights issue money exactly as promised, largely to reduce debt. The reduction in borrowings may slightly improve interest costs going forward, but there is no new business trigger in this filing – it is purely an accountability disclosure rather than a price-moving event.